0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Inadvertent Vitreous Staining With Trypan Blue in Pseudoexfoliation Syndrome FREE

Ahmad Kheirkhah, MD; Rahman Nazari, MD; Ramak Roohipour, MD
[+] Author Affiliations

Author Affiliations: Farabi Eye Hospital, Eye Research Center, Tehran University of Medical Sciences, Tehran, Iran.


Arch Ophthalmol. 2010;128(10):1372-1373. doi:10.1001/archophthalmol.2010.236.
Text Size: A A A
Published online

Trypan blue is commonly used for anterior capsular staining during cataract surgery. Although this technique is safe,1 vitreous staining with trypan blue during cataract surgery has been reported in patients with history of trauma.24 Here we report a case of vitreous staining with this dye during phacoemulsification in an eye with pseudoexfoliation syndrome without clinically noticeable zonulysis.

A 73-year-old woman had reduced vision in the right eye with no history of trauma. The visual acuity was light perception, and slitlamp examination showed a mature white cataract in the right eye and the presence of pseudoexfoliation syndrome in both eyes with no clinical signs of phacodonesis or iridodonesis.

The patient underwent cataract surgery. After creating a clear corneal incision, trypan blue at a concentration of 1 mg/mL was applied on the anterior capsule beneath an air bubble. After 15 seconds, the dye was irrigated and the anterior chamber was filled with viscoelastic material. Continuous curvilinear capsulorrhexis was then performed and the nucleus was removed by phacoemulsification. No evidence of zonulysis was noted during the surgery. At completion of nucleus fragments removal, the red reflex was absent and a dull blue glow was noticed instead. Intraoperative indirect ophthalmoscopy failed to allow visualization of the fundus. Surgery was completed with implantation of a foldable intraocular lens in the bag.

On the first postoperative day, uncorrected visual acuity was 20/50 with normal intraocular pressure. The relative afferent pupillary defect could not be evaluated owing to sluggish pupillary reaction in both eyes. Slitlamp examination showed mild corneal edema, absence of significant anterior chamber inflammatory reaction, and presence of a blue fundal glow (Figure, A). Indirect ophthalmoscopy revealed only an intense bluish hue with no visible details of fundus; however, B-scan echography results were unremarkable. The blue hue gradually decreased and after 10 days it disappeared completely (Figure, B). At that time, the patient's uncorrected visual acuity was 20/20; slitlamp examination results were normal and fundus examination showed normal macula and retina. No complication was noted during 6 months of follow-up.

Place holder to copy figure label and caption
Figure.

Inadvertent vitreous staining with trypan blue during cataract surgery in an eye with pseudoexfoliation syndrome. On the first postoperative day, a blue fundal glow was seen at slitlamp examination (A), which disappeared completely by 10 days after surgery (B).

Graphic Jump Location

Inadvertent staining of the vitreous with trypan blue during cataract surgery has been reported before.24 In all 3 reported cases, a history of trauma was present and compromised zonular integrity due to trauma was assumed to be the cause of this phenomenon. In our case, although there was no clinical evidence of phacodonesis or iridodonesis, the compromised zonular apparatus due to pseudoexfoliation syndrome probably allowed the percolation of trypan blue into the vitreous.

In the previously reported cases, the dye disappeared from the vitreous within 1 week.3,4 In our case, even though the vitreous staining was so intense that fundus examination was not possible, the trypan blue disappeared from the vitreous within 10 days. Temporary retinal toxic effects have been shown in an eye with inadvertent vitreous staining with 0.06% trypan blue4 and in a rabbit study using a 0.2% concentration5; however, in our case, staining with a 0.1% concentration did not show any clinically abnormal retinal finding after 10 days. Additional diagnostic evaluation is needed to clarify the damage caused by this staining.

Based on our case, it is advised to be more cautious in using trypan blue in patients with pseudoexfoliation syndrome even if there is no significant clinical zonulysis. In these cases, extra measures may be taken, such as premixing trypan blue with viscoelastic material,3,6 to prevent vitreous staining.

Correspondence: Dr Kheirkhah, Farabi Eye Hospital, Qazvin Square, South Kargar Street, Tehran, Iran (akheirkh@yahoo.com).

Financial Disclosure: None reported.

Farah  MEMaia  MFurlani  B  et al.  Current concepts of trypan blue in chromovitrectomy. Dev Ophthalmol 2008;4291- 100
PubMed
Chowdhury  PKRaj  SMVasavada  AR Inadvertent staining of the vitreous with trypan blue. J Cataract Refract Surg 2004;30 (1) 274- 276
PubMed Link to Article
Gaur  AKayarkar  VV Inadvertent vitreous staining. J Cataract Refract Surg 2005;31 (4) 649
PubMed Link to Article
Bacsal  KMChee  SP Trypan blue-associated retinal toxicity post complicated cataract surgery. Eye (Lond) 2006;20 (11) 1310- 1311
PubMed Link to Article
Veckeneer  Mvan Overdam  KMonzer  J  et al.  Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001;239 (9) 698- 704
PubMed Link to Article
Lanzl  IMMertz  MM Why mix trypan blue with viscoelastic agents? J Cataract Refract Surg 2003;29 (2) 237
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure.

Inadvertent vitreous staining with trypan blue during cataract surgery in an eye with pseudoexfoliation syndrome. On the first postoperative day, a blue fundal glow was seen at slitlamp examination (A), which disappeared completely by 10 days after surgery (B).

Graphic Jump Location

Tables

References

Farah  MEMaia  MFurlani  B  et al.  Current concepts of trypan blue in chromovitrectomy. Dev Ophthalmol 2008;4291- 100
PubMed
Chowdhury  PKRaj  SMVasavada  AR Inadvertent staining of the vitreous with trypan blue. J Cataract Refract Surg 2004;30 (1) 274- 276
PubMed Link to Article
Gaur  AKayarkar  VV Inadvertent vitreous staining. J Cataract Refract Surg 2005;31 (4) 649
PubMed Link to Article
Bacsal  KMChee  SP Trypan blue-associated retinal toxicity post complicated cataract surgery. Eye (Lond) 2006;20 (11) 1310- 1311
PubMed Link to Article
Veckeneer  Mvan Overdam  KMonzer  J  et al.  Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001;239 (9) 698- 704
PubMed Link to Article
Lanzl  IMMertz  MM Why mix trypan blue with viscoelastic agents? J Cataract Refract Surg 2003;29 (2) 237
PubMed Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles